News Details

Abeona Therapeutics Reinitiates Enrollment in EB-101 Pivotal Phase 3 VIITALâ„¢ Study in RDEB after COVID-19 Related Pause and Announces Progress in Patient Enrollment in MPS III Studies

About Abeona Therapeutics Inc.

Price Chart